Investment Required
Rs 50 K- Rs 150 K
Last updated on
30 Jul 2019
Product added on
30 Jul 2019
We are
looking for distributors
Space Required
500 sq ft
Investment Required
Rs 50 K- Rs 150 K
Brand
List Attached
Moxonidine (INN) is a new-generation alpha-2/imidazoline receptor agonist antihypertensive drug licensed for the treatment of mild to moderate essential hypertension.[5][6] It may have a role when thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistancesyndrome, apparently independent of blood pressure reduction.
Sample Available
Yes
Payment Terms
Delivery Point (DP)
Payment Terms
Days after Acceptance (DA)
Payment Terms
Cash in Advance (CID)
Payment Terms
Cash on Delivery (COD)
Payment Terms
Cheque
Payment Terms
Cash Against Delivery (CAD)
Payment Terms
Cash Advance (CA)
Main Domestic Market
All India
Sample Policy
Sample costs shipping and taxes has to be paid by the buyer